Insider Trading activities of Enzo Biochem Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Enzo Biochem Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Enzo Biochem Inc since year 2005. Table 2 shows the detailed insider transactions of Enzo Biochem Inc since 2005. The reporting company's ticker symbol is ENZ. The reporting company's CIK number is 316253.
The total value of stock buying since 2005 is $1,242,310.
The total value of stock sales since 2005 is $6,657,191.
The total value of stock option exercises since 2005 is $2,477,004.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Enzo Biochem Inc (ENZ).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 233,398 $2,337,310 413,367 $1,237,264
2017-06 0 $0 15,800 $160,054 0 $0
2016-03 0 $0 40,282 $167,799 0 $0
2016-01 0 $0 2,500 $11,640 0 $0
2014-10 0 $0 15,900 $78,433 0 $0
2011-11 40,000 $91,480 0 $0 0 $0
2010-12 0 $0 12,724 $65,146 0 $0
2010-10 0 $0 8,000 $34,400 0 $0
2010-08 0 $0 2,500 $11,175 0 $0
2010-06 0 $0 5,000 $21,480 0 $0
2010-04 0 $0 30 $186 0 $0
2010-03 0 $0 5,000 $30,740 0 $0
2009-10 6,600 $50,826 0 $0 0 $0
2008-10 0 $0 580 $3,103 0 $0
2008-09 0 $0 0 $0 212,654 $1,158,961
2008-07 82,645 $1,100,004 0 $0 0 $0
2008-02 0 $0 3,500 $35,595 4,000 $0
2008-01 0 $0 0 $0 895 $9,558
2007-12 0 $0 147,997 $1,930,156 0 $0
2007-10 0 $0 118,476 $1,540,378 0 $0
2007-01 0 $0 0 $0 11,247 $0
2006-07 0 $0 0 $0 8,503 $71,221
2005-07 0 $0 13,570 $229,596 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Enzo Biochem Inc insiders (ENZ)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-31 Bortz Gregory M. Sale 42,005 9.82 412,489
2017-10-31 Bortz Gregory M. Option Ex 59,455 2.88 171,230
2017-10-31 Perlysky Dov Sale 42,000 9.81 412,020
2017-10-31 Perlysky Dov Option Ex 59,455 2.88 171,230
2017-10-27 O'brien James Michael (EVP of Finance) Sale 22,866 10.28 235,062
2017-10-27 O'brien James Michael (EVP of Finance) Option Ex 22,866 3.50 80,031
2017-10-25 Rabbani Elazar (CEO, Chn. of the Brd. and Sec.) Sale 72,401 10.09 730,526
2017-10-25 Rabbani Elazar (CEO, Chn. of the Brd. and Sec.) Option Ex 159,091 3.00 477,273
2017-10-25 Weiner Barry W (President, CFO, Treasurer, PAO) Sale 54,126 10.11 547,213
2017-10-25 Weiner Barry W (President, CFO, Treasurer, PAO) Option Ex 112,500 3.00 337,500
2017-06-13 O'brien James Michael (EVP of Finance) Sale 15,800 10.13 160,054
2016-03-11 Kasten Bernard L Sale 10,054 4.40 44,227
2016-03-10 Kasten Bernard L Sale 30,228 4.09 123,572
2016-01-21 Kasten Bernard L Sale 2,500 4.66 11,640
2014-10-24 Kasten Bernard L Sale 12,500 4.94 61,750
2014-10-23 Kasten Bernard L Sale 3,400 4.91 16,683
2011-11-16 Rabbani Elazar (CEO and Secretary) Buy 20,000 2.29 45,780
2011-11-16 Weiner Barry W (Pres, CFO, Princ AO and Treasr) Buy 20,000 2.29 45,700
2010-12-15 Balezentis Carl W (Pres., Enzo Life Sciences) Sale 12,724 5.12 65,146
2010-10-22 Kent Stephen B H (Director) Sale 8,000 4.30 34,400
2010-08-05 Kent Stephen B H (Director) Sale 2,500 4.47 11,175
2010-06-11 Kent Stephen B H (Director) Sale 5,000 4.30 21,480
2010-04-07 Balezentis Carl W (Pres., Enzo Life Sciences) Sale 30 6.23 186
2010-03-15 Kent Stephen B H (Director) Sale 5,000 6.15 30,740
2009-10-15 Krenitsky Kevin (President, Enzo Clinical Labs) Buy 6,600 7.70 50,826
2008-10-30 Balezentis Carl W (President, Enzo Life Sciences) Sale 580 5.35 3,103
2008-09-26 Sias John B (Director) Option Ex 6,078 5.45 33,125
2008-09-23 Bass Herbert B (Senior Vice President, Finance) Option Ex 6,078 5.45 33,125
2008-09-23 Kelker Norman E (Senior Vice President) Option Ex 12,155 5.45 66,244
2008-09-23 Goldberg David C (VP, Business Development) Option Ex 6,078 5.45 33,125
2008-09-23 Rabbani Elazar (Chairman and CEO) Option Ex 60,755 5.45 331,114
2008-09-23 Weiner Barry W (President and CFO) Option Ex 60,755 5.45 331,114
2008-09-23 Rabbani Shahram K (Treasurer and Secretary) Option Ex 60,755 5.45 331,114
2008-07-18 Rabbani Shahram K (Treasurer, Secretary) Buy 82,645 13.31 1,100,004
2008-02-05 Kent Stephen B H (Director) Sale 3,500 10.17 35,595
2008-02-04 Goldberg David C (VP, Business Development) Option Ex 2,000 .00 0
2008-02-04 Thalenfeld Barbara E (VP, Corporate Development) Option Ex 2,000 .00 0
2008-01-14 Delucca John (Director) Option Ex 895 10.68 9,558
2007-12-20 Kelker Norman E (Senior Vice President) Sale 13,600 12.76 173,481
2007-12-20 Rabbani Shahram K (Treasurer, Secretary) Sale 74,797 13.03 974,604
2007-12-19 Rabbani Shahram K (Treasurer, Secretary) Sale 59,600 13.12 782,071
2007-10-26 Thalenfeld Barbara E (VP, Corporate Development) Sale 10,376 12.48 129,492
2007-10-18 Rabbani Shahram K (Treasurer and Secretary) Sale 80,800 13.03 1,053,147
2007-10-17 Rabbani Shahram K (Treasurer and Secretary) Sale 27,300 13.10 357,739
2007-01-09 Engelhardt Dean (Executive Vice President) Option Ex 11,247 .00 0
2006-07-30 Goldberg David C (VP, Business Development) Option Ex 6,700 10.63 71,221
2006-07-06 Thalenfeld Barbara E (VP, Corporate Development) Option Ex 1,803 .00 0
2005-07-19 Kelker Norman E (Senior Vice Presiden) Sale 10,000 16.61 166,050
2005-07-11 Thalenfeld Barbara E (Vice President, Corp) Sale 3,570 17.80 63,546

Insider trading activities including stock purchases, stock sales, and option exercises of ENZ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Enzo Biochem Inc (symbol ENZ, CIK number 316253) see the Securities and Exchange Commission (SEC) website.